International Biotechnology Trust PLC Intercept Pharmaceuticals, Inc. Transaction History

International Biotechnology Trust PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$11.23 - $19.59 $4,952 - $8,639	441 New	441 $32 Million
Q3 2017 Mar 02, 2018	SELL	$57.01 - $118.75 $635,946 - $1.32 Million	-11,155 Closed	0 $0
Q1 2017 Mar 02, 2018	SELL	N/A	-18,400 Reduced 62.26%	11,155 $1.26 Million
Q4 2016 Mar 02, 2018	BUY	N/A	29,555	29,555 $3.21 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.